Scientists at Washington University School of Medicine in St. Louis have implicated a type of immune cell in the development of chronic lung disease that sometimes is triggered following a respiratory viral infection. The evidence suggests that activation of this immune cell serves as an early switch that, when activated, drives progressive lung diseases, including asthma and chronic obstructive pulmonary disease (COPD).
Do I have COVID-19 or is it something else? Bobby Tajudeen, MD, director of rhinology, sinus surgery and skull base surgery at Rush University Medical Center explains the differences between common smell loss and smell loss as a COVID-19 symptom and when to see a specialist.
Study demonstrates how a subset of common gut bacteria renders mice resistant to viral infections.
Watching a viral infection happen in real time is like a cross between a zombie horror film, paint drying, and a Bollywood epic on repeat. Over a 10-hour span, chemical engineers from Michigan Tech watched viral infections happen with precision inside a microfluidics device and can measure when the infection cycle gets interrupted by an antiviral compound.
The raging lung inflammation that can contribute to death from the flu can be stopped in its tracks by a drug derived from a naturally occurring human protein, a new animal study suggests.
Article title: Pregnancy and COVID-19 Authors: Elizabeth A.N. Wastnedge, Rebecca M. Reynolds, Sara R. van Boeckel, Sarah J. Stock, Fiona Denison, Jacqueline A. Maybin, Hilary O.D. Critchley From the authors: “From the current evidence base, it is difficult to draw…